The time course of markers of neutrophil extracellular traps in patients undergoing revascularisation for acute myocardial infarction or stable angina pectoris

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Helseth, Ragnhild ^a,b   Solheim, Svein ^a   Arnesen, Harald ^a,b   Seljeflot, Ingebjørg ^a,b   Opstad, Trine Baur ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; DOUBLE STRANDED DNA; PENTRAXIN 3; TROPONIN T; DNA; NUCLEOSOME;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DOUBLE-STRANDED DNA VIRUS; EXTRACELLULAR TRAP; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HUMAN; LEUKOCYTE COUNT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOSOME; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; ACUTE DISEASE; BLOOD; CARDIAC MUSCLE; CHEMISTRY; COHORT ANALYSIS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; METABOLISM; MIDDLE AGED; PATHOLOGY; THROMBOSIS; TIME FACTOR;

ACUTE DISEASE; AGED; ANGINA, STABLE; COHORT STUDIES; CREATINE KINASE, MB FORM; DNA; EXTRACELLULAR TRAPS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; NUCLEOSOMES; PERCUTANEOUS CORONARY INTERVENTION; THROMBOSIS; TIME FACTORS; TROPONIN T;

EID: 85009135248     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/2182358     Document Type: Article

References (37)

1. S. Chia, J. T. Nagurney, D. F. M. Brown, et al., Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for st-elevation myocardial infarction, The American Journal of Cardiology, vol. 103, no. 3, pp. 333-337, 2009.
2. L. Guasti, F. Dentali, L. Castiglioni, et al., Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. A systematic review on more than 34, 000 subjects, Thrombosis and Haemostasis, vol. 106, no. 4, pp. 591-599, 2011.
3. R. Latini, A. P. Maggioni, G. Peri, et al., Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction, Circulation, vol. 110, no. 16, pp. 2349-2354, 2004.
4. D.-H. Lee, H.-K. Jeon, J.-H. You, et al., Pentraxin 3 as a novel marker predicting congestive heart failure in subjects with acute coronary syndrome, Korean Circulation Journal, vol. 40, no. 8, pp. 370-376, 2010.
5. S. Baldus, C. Heeschen, T. Meinertz, et al., Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes, Circulation, vol. 108, no. 12, pp. 1440-1445, 2003.
6. D. A. Morrow, M. S. Sabatine, M.-L. Brennan, et al., Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18, European Heart Journal, vol. 29, no. 9, pp. 1096-1102, 2008.
7. V. Brinkmann, U. Reichard, C. Goosmann, et al., Neutrophil extracellular traps kill bacteria, Science, vol. 303, no. 5663, pp. 1532-1535, 2004.
8. A. Mangold, S. Alias, T. Scherz, et al., Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of STsegment resolution and infarct size, Circulation Research, vol. 116, no. 7, pp. 1182-1192, 2015.
9. J. Riegger, R. A. Byrne, M. Joner, et al., Histopathological evaluation of thrombus in patients presenting with stent thrombosis. Amulticenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium, European Heart Journal, vol. 37, no. 19, pp. 1538.1-1549, 2016.
10. J. I. Borissoff, I. A. Joosen, M. O. Versteylen, et al., Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state, Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 8, pp. 2032-2040, 2013.
11. C. P.-Y. Chang, R.-H. Chia, T.-L. Wu, K.-C. Tsao, C.-F. Sun, and J. T. Wu, Elevated cell-free serum DNA detected in patients with myocardial infarction, Clinica Chimica Acta, vol. 327, no. 1-2, pp. 95-101, 2003.
12. M. Cui, M. Fan, R. Jing, et al., Cell-free circulating DNA: a new biomarker for the acute coronary syndrome, Cardiology, vol. 124, no. 2, pp. 76-84, 2013.
13. A. Shimony, D.Zahger, H. Gilutz, et al., Cell freeDNAdetected by a novel method in acute ST-elevation myocardial infarction patients, Acute Cardiac Care, vol. 12, no. 3, pp. 109-111, 2010.
14. A. Destouni, C. Vrettou, D. Antonatos, et al., Cell-free DNA levels in acute myocardial infarction patients during hospitalization, Acta Cardiologica, vol. 64, no. 1, pp. 51-57, 2009.
15. D. Antonatos, S. Patsilinakos, S. Spanodimos, P. Korkonikitas, and D. Tsigas, Cell-free DNA levels as a prognostic marker in acute myocardial infarction, Annals of the New York Academy of Sciences, vol. 1075, pp. 278-281, 2006.
16. A. Warnatsch, M. Ioannou, Q. Wang, and V. Papayannopoulos, Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis, Science, vol. 349, no. 6245, pp. 316-320, 2015.
17. J. S. Knight, W. Luo, A. A. O'Dell, et al., Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses inmurine models of atherosclerosis, Circulation Research, vol. 114, no. 6, pp. 947-956, 2014.
18. C. Kaiser, M. Koranda, B. Kitzler, et al., Belowground carbon allocation by trees drives seasonal patterns of extracellular enzyme activities by altering microbial community composition in a beech forest soil, New Phytologist, vol. 187, no. 3, pp. 843-858, 2010.
19. M.-L. von Brühl, K. Stark, A. Steinhart, et al., Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo, Journal of Experimental Medicine, vol. 209, no. 4, pp. 819-835, 2012.
20. S. Massberg, L. Grahl, M.-L. von Bruehl, et al., Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases, Nature Medicine, vol. 16, no. 8, pp. 887-896, 2010.
21. S. H. C. Mai, M. Khan, D. J. Dwivedi, et al., Delayed but not early treatment with dnase reduces organ damage and improves outcome in a murine model of sepsis, Shock, vol. 44, no. 2, pp. 166-172, 2015.
22. S. Solheim, H. K. Grøgaard, P. Hoffmann, H. Arnesen, and I. Seljeflot, Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris, Scandinavian Journal of Clinical and Laboratory Investigation, vol. 68, no. 7, pp. 555-562, 2008.
23. R. Helseth, S. Solheim, T. Opstad, P. Hoffmann, H. Arnesen, and I. Seljeflot, The time profile of pentraxin 3 in patientswith acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention, Mediators of Inflammation, vol. 2014, Article ID 608414, 5 pages, 2014.
24. T. J. Gould, T. T. Vu, L. L. Swystun, et al., Neutrophil extracellular traps promote thrombin generation through plateletdependent and platelet-independent mechanisms, Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 9, pp. 1977-1984, 2014.
25. Y. Döring, H. D. Manthey, M. Drechsler, et al., Auto-Antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis, Circulation, vol. 125, no. 13, pp. 1673-1683, 2012.
26. C. Carmona-Rivera, W. Zhao, S. Yalavarthi, and M. J. Kaplan, Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2, Annals of the Rheumatic Diseases, vol. 74, no. 7, pp. 1417-1424, 2015.
27. P. Libby, and P. Theroux, Pathophysiology of coronary artery disease, Circulation, vol. 111, no. 25, pp. 3481-3488, 2005.
28. R. K. Schindhelm, L. P. van der Zwan, T. Teerlink, and P. G. Scheffer, Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? Clinical Chemistry, vol. 55, no. 8, pp. 1462-1470, 2009.
29. A. T. Askari, M.-L. Brennan, X. Zhou, et al., Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction, Journal of Experimental Medicine, vol. 197, no. 5, pp. 615-624, 2003.
30. N. Vasilyev, T. Williams, M.-L. Brennan, et al., Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size aftermyocardial infarction, Circulation, vol. 112, no. 18, pp. 2812-2820, 2005.
31. L. Ge, X. Zhou, W.-J. Ji, et al., Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy, American Journal of Physiology. Heart and Circulatory Physiology, vol. 308, no. 5, pp. H500-H509, 2015.
32. H. D. Lewis, J. Liddle, J. E. Coote, et al., Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation, Nature Chemical Biology, vol. 11, no. 3, pp. 189-191, 2015.
33. G. P. Fadini, L. Menegazzo, M. Rigato, et al., NETosis delays diabetic wound healing in mice and humans, Diabetes, vol. 65, no. 4, pp. 1061-1071, 2016.
34. E. Tarantino, P. Amadio, I. Squellerio, et al., Role of thromboxanedependent platelet activation in venous thrombosis: aspirin effects in mouse model, Pharmacological Research, vol. 107, pp. 415-425, 2016.
35. D. M. Sayah, B. Mallavia, F. Liu, et al., Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation, American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 4, pp. 455-463, 2015.
36. M. J. Lapponi, A. Carestia, V. I. Landoni, et al., Regulation of neutrophil extracellular trap formation by anti-inflammatory drugs, Journal of Pharmacology and ExperimentalTherapeutics, vol. 345, no. 3, pp. 430-437, 2013.
37. C. W. Kessinger, J. W. Kim, P. K. Henke, et al., Statins improve the resolution of establishedmurine venous thrombosis: reductions in thrombus burden and vein wall scarring, PLoS ONE, vol. 10, no. 2, Article ID e0116621, 2015.